The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers

Afficher d'autres versions (1)

Proteomics can help to discover and quantify novel biomarkers and we show how this is achieved using liver fibrosis as an example. Liver biopsy is the reference standard for assessing liver fibrosis and serum biomarkers are less invasive. The severity of liver fibrosis can be determined using immuno...

Description complète

Détails bibliographiques
Auteurs principaux:	Gangadharan, B, Kumar, A, Barnes, E, Klenerman, P, Dwek, R, Zitzmann, N
Format:	Journal article
Publié:	Wiley 2016

Documents similaires

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
par: Gangadharan, B, et autres
Publié: (2016)

PTH-092 Discovery and quantitation of novel liver fibrosis biomarkers using proteomics
par: Gangadharan, B, et autres
Publié: (2015)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients using proteomics
par: Gangadharan, B, et autres
Publié: (2014)

New proteomics approaches for discovering biomarkers: Searching for liver fibrosis markers in hepatitis c patients
par: Gangadharan, B, et autres
Publié: (2012)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
par: Gangadharan, B, et autres
Publié: (2016)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
par: Gangadharan, B, et autres
Publié: (2014)

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
par: Gangadharan, B, et autres
Publié: (2007)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
par: Gangadharan, B, et autres
Publié: (2011)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
par: Gangadharan, B, et autres
Publié: (2011)

Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
par: Gangadharan, B, et autres
Publié: (2011)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study
par: Gangadharan, B, et autres
Publié: (2012)

Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
par: Gangadharan, B, et autres
Publié: (2012)

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
par: Gangadharan, B, et autres
Publié: (2008)

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
par: Gangadharan, B, et autres
Publié: (2010)

LC-MS based discovery of novel protein biomarkers and their quantitation in HCV fibrosis and NASH diseased human serum
par: Kumar, A, et autres
Publié: (2014)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
par: Bevin Gangadharan, et autres
Publié: (2012-01-01)

Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
par: Pardo, M, et autres
Publié: (2007)

Towards the first antibody-free serum biomarker assay for NAFLD
par: Gangadharan, B, et autres
Publié: (2017)

Discovery and quantitation of novel liver fibrosis biomarkers in hepatitis C patients
par: Gangadharan, B
Publié: (2017)

Towards the first antibody-free serum biomarker assay for NAFLD
par: Gangadharan, B, et autres
Publié: (2017)

Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection.
par: Narayan, R, et autres
Publié: (2009)

Applying proteomics technology to platelet research.
par: García, A, et autres
Publié: (2005)

Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.
par: Woodhouse, S, et autres
Publié: (2010)

SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
par: Yi Luo, et autres
Publié: (2021-05-01)

Two dimensional gel electrophoresis using narrow pH 3-5.6 immobilised pH gradient strips identifies potential novel disease biomarkers in plasma or serum
par: Gangadharan, B, et autres
Publié: (2011)

Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review.
par: Bharucha, T, et autres
Publié: (2019)

Differential proteome analysis of CRP-activated platelets
par: Garcia, A, et autres
Publié: (2005)

Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example
par: Kumar, A, et autres
Publié: (2017)

Diagnostics of Fibrosis in Alcoholic Liver Damage
par: E. N. Travenko, et autres
Publié: (2019-09-01)

Non-invasive Diagnostics of Liver Fibrosis
par: Mihaylov R., et autres
Publié: (2017-05-01)

Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome.
par: Antrobus, R, et autres
Publié: (2009)

Use of iminosugar derivatives to inhibit ion channel activity
par: Zitzmann, N, et autres
Publié: (2004)

Serum biomarkers for liver fibrosis assessment
par: Maroto-García Julia, et autres
Publié: (2023-11-01)

Proteome analysis of human uveal melanoma cells by two-dimensional gel electrophoresis and mass spectrometry
par: Pardo, M, et autres
Publié: (2005)

Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
par: Pardo, M, et autres
Publié: (2005)

Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children
par: Yasser E Nassef, et autres
Publié: (2013-11-01)

Salivary biomarkers and proteomics: future diagnostic and clinical utilities
par: M. Castagnola, et autres
Publié: (2017-04-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
par: E V Vinnitskaia, et autres
Publié: (2013-02-01)

Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry
par: García, A, et autres
Publié: (2004)

Multiple reaction monitoring and multiple reaction monitoring cubed based assay for the quantitation of apolipoprotein F
par: Kumar, A, et autres
Publié: (2016)